| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |